Fachbereich
HOSPITAL UNIVERSITARIO RUBER
Publikationen (66) Publikationen, an denen Forscher/innen teilgenommen haben
2021
-
A novel circulating microRNA for the detection of acute myocarditis
New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027
-
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
Breast Cancer Research, Vol. 23, Núm. 1
-
A plain language summary of the ASCENT study: Sacituzumab Govitecan for metastatic triple-negative breast cancer
Future Oncology, Vol. 17, Núm. 30, pp. 3911-3924
-
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Annals of Oncology, Vol. 32, Núm. 12, pp. 1571-1581
-
Ansiedad y percepción de los estudiantes de Medicina en su rotación clínica en Obstetricia durante la pandemia por COVID-19
Revista Española de Educación Médica, Vol. 2, Núm. 1, pp. 13-21
-
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer
Cancers, Vol. 13, Núm. 17
-
Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
Journal of Geriatric Cardiology, Vol. 18, Núm. 1, pp. 20-29
-
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Annals of Oncology, Vol. 32, Núm. 9, pp. 1148-1156
-
Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement
IJC Heart and Vasculature, Vol. 36
-
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
The Lancet Oncology, Vol. 22, Núm. 6, pp. 858-871
-
Clinical Validation of a 3-Dimensional Ultrafast Cardiac Magnetic Resonance Protocol Including Single Breath-Hold 3-Dimensional Sequences
JACC: Cardiovascular Imaging, Vol. 14, Núm. 9, pp. 1742-1754
-
Clinical, pathological, and molecular features of breast carcinoma cutaneous metastasis
Cancers, Vol. 13, Núm. 21
-
Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart
Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 870-877
-
Compassionate use of remdesivir in children with COVID-19
European Journal of Pediatrics, Vol. 180, Núm. 4, pp. 1317-1322
-
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study
Frontiers in Medicine, Vol. 8
-
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer ☆
Annals of Oncology, Vol. 32, Núm. 12, pp. 1475-1495
-
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
Trials, Vol. 22, Núm. 1
-
Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial
JAMA Oncology, Vol. 7, Núm. 4, pp. 573-584
-
Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review
Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 245-257
-
Epithelial mesenchymal transition and immune response in metaplastic breast carcinoma
International Journal of Molecular Sciences, Vol. 22, Núm. 14